Medical Devices: Page 4
-
Bayesian Health gets FDA nod for AI sepsis detection tool
Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.
By Elise Reuter • May 12, 2026 -
Stryker values Amplitude Vascular purchase at up to $835M
The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.
By Susan Kelly • May 12, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineRobotic surgery's innovation boom
Surgical robotics is one of the most exciting spaces in the medical device industry, with companies developing new systems and battling for market share.
By MedTech Dive staff -
HistoSonics seeks FDA de novo authorization in kidney cancer
Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.
By Nick Paul Taylor • May 12, 2026 -
Retrieved from Medtronic on May 11, 2026
Medtronic to close California site amid restructuring
The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several businesses within its cardiovascular portfolio.
By Susan Kelly • May 11, 2026 -
Mobia Medical CEO eyes large market for stroke rehab
With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.
By Elise Reuter • May 11, 2026 -
BD appoints Vitor Roque as permanent CFO
The company made Roque’s appointment permanent after considering external candidates for the role.
By Nick Paul Taylor • May 11, 2026 -
Tandem to file tubeless insulin pump with FDA this quarter
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.
By Elise Reuter • May 8, 2026 -
Retrieved from Stryker Corporation on January 06, 2025
Stryker closes Amplitude Vascular acquisition
With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.
By Susan Kelly • May 8, 2026 -
Roche to acquire digital pathology firm PathAI for up to $1.05B
Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.
By Elise Reuter • May 7, 2026 -
Neptune Medical’s GI robot succeeds in colonoscopy study
The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.
By Susan Kelly • May 6, 2026 -
Insulet raises revenue expectations for 2026
CEO Ashley McEvoy also shared an update on the company’s recent recall of insulin patch pumps.
By Elise Reuter • May 6, 2026 -
J&J’s Ottava robot meets goals in gastric bypass study
The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.
By Susan Kelly • May 6, 2026 -
Integra reappoints Stuart Essig as CEO
Essig filled the vacancy created when Mojdeh Poul and the Integra board mutually decided to end her time as CEO after less than 18 months.
By Nick Paul Taylor • May 6, 2026 -
Mobia Medical plans IPO
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each.
By Nick Paul Taylor • May 5, 2026 -
Retrieved from Viatris on May 05, 2026
Edwards names Theodora Mistras as CFO
Mistras, who joins the heart valve company after two years as CFO at pharmaceutical firm Viatris, also brings investment banking experience.
By Susan Kelly • May 5, 2026 -
Olympus, EndoRobotics forge distribution pact
The deal to distribute EndoRobotics’ endoscopic robotic devices for gastroenterology follows Olympus’ agreement to co-launch Swan EndoSurgical, a startup developing a robotic GI platform.
By Susan Kelly • May 4, 2026 -
Insulet starts study of closed loop insulin delivery system
Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.
By Elise Reuter • May 4, 2026 -
Top medtech executive moves in 2026
Integra LifeSciences has reappointed Stuart Essig as CEO, and Edwards Lifesciences and BD named new CFOs. Read MedTech Dive’s roundup for all the details.
By MedTech Dive Staff • Updated May 20, 2026 -
Abbott gets FDA nod, CE mark for AI-enabled imaging device
The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.
By Nick Paul Taylor • May 4, 2026 -
Teleflex hires Jason Weidman as CEO
After two decades at Medtronic, Weidman will join Teleflex as the medtech company reshapes its portfolio.
By Susan Kelly • April 30, 2026 -
FDA advises users of Trividia glucometer to switch to alternatives
The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to other blood glucose meters.
By Nick Paul Taylor • April 30, 2026 -
Medtronic wins FDA approval for updated mitral replacement valve
Surgeons have performed initial implants of the Mosaic Neo valve at centers across the U.S., as well as the first robotic implantation.
By Susan Kelly • April 29, 2026 -
Profile
Surgeries are moving to ASCs. Distalmotion wants its robot to drive the shift.
CEO Greg Roche says ambulatory surgery centers have largely lacked access to robots for performing soft tissue procedures, until now.
By Susan Kelly • April 29, 2026 -
Medtronic secures CE mark for Stealth AXiS surgical system
Receiving the clearance positions Medtronic to launch a product that combines surgical planning, navigation and robotics in Europe.
By Nick Paul Taylor • April 29, 2026 -
J&J starts head-to-head PFA trial against Boston Scientific device
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
By Nick Paul Taylor • April 28, 2026